Mechanistic investigations demonstrate that SIRT6 safeguards DNA integrity by regulating chromatin accessibility at sites of damage, and recent PROTAC-based studies show that pharmacological depletion of SIRT6 impairs DNA repair capacity, sensitizing HCC cells to radiotherapy and kinase inhibitors [98]. This evidence concerns the gene SIRT6 and hepatocellular carcinoma.